The U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 6 (VISN 6) awarded a Blanket Purchase Agreement (BPA) to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, to provide BinaxNOW COVID-19 antigen test kits. The BPA, valued at $240,608.97, has an ultimate completion date of September 30, 2024 and was awarded without any set-aside designations. This BPA is part of Abbott Rapid DX North America LLC's Federal Supply Schedule (FSS) 65-VII contract...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded a single award Blanket Purchase Agreement to Abbott Rapid DX North America LLC for Abbott Binax ID NOW COVID-19 antigen test kits. The potential value of the BPA is $744,842.40 to supply test kits through December 31, 2022 for use across VISN 1 facilities.
The originating pre-solicitation notice sought market research for a five-year BPA to supply Abbott Binax NOW COVID Ag Card...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 15 has awarded an indefinite delivery contract to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, to provide COVID-19 antigen testing supplies and services. The single-award contract has a ceiling value of $995,165.44 and runs through January 2026.
Under this contract, Abbott will deliver its BinaxNOW rapid COVID-19 antigen tests and related diagnostic materials to support coronavirus testing...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded Abbott Rapid DX North America LLC, doing business as Alere, an indefinite-delivery/indefinite-quantity contract with a potential value of $5.2 million to provide COVID-19 testing supplies. Abbott Laboratories is the prime contractor supplying tests under its parent General Services Administration Schedule 65-VII for in vitro diagnostics, reagents, and tests.
Three firm fixed price...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded multiple firm fixed price calls against Abbott Rapid DX North America LLC's General Services Administration Federal Supply Schedule contract for Invitro Diagnostics, Reagents, and Tests. Abbott Rapid DX North America LLC, doing business as Alere and a subsidiary of Abbott Laboratories, will deliver Abbott's BINAXNOW COVID-19 rapid antigen tests to the VA location in Lockhart,...
This federal contract IDV is a Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Abbott Rapid DX North America LLC, doing business as Alere, a subsidiary of Abbott Laboratories Inc. The BPA, valued at $4,676,479.65, is under the VA's GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests. It has an ultimate completion date of December 31, 2025.
The contract provides for the delivery of Abbott BinaxNOW...
The U.S. Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) to Abbott Laboratories Inc., a healthcare manufacturer, to provide a variety of infectious disease testing services and related medical equipment and supplies. The contract, valued at up to $1.3 million, utilizes Abbott's existing General Services Administration (GSA) Federal Supply Schedule contract for Critical Analyzers, Laboratory (FSS-66-III) to enable streamlined procurement of diagnostic testing...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 15 to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide COVID-19 testing equipment, molecular analyzers, and reagents. The BPA, which has a total ceiling value of $6,325,044.25, utilizes the GSA Schedule 65-VII contract for in vitro diagnostics, reagents, and tests.
Under the BPA, the VA has issued multiple firm-fixed price delivery orders with...
The Department of Veterans Affairs awarded Abbott Laboratories Inc. a blanket purchase agreement to provide SARS-CoV-2 serology test kits and related materials. Abbott Laboratories will deliver these supplies through its Abbott Diagnostics Division. The sole source BPA, valued at $556,590, enables the VA to fulfill recurring needs for these medical products on an as-needed basis through September 2022.
Against this BPA, the VA issued an initial firm fixed price call worth $131,832.46 to...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a Blanket Purchase Agreement (BPA) to Abbott Laboratories Inc., a major pharmaceutical and medical device company, to provide testing supplies and reagents. The BPA, valued at up to $640,000, is issued against Abbott's existing GSA Schedule 65-VII contract for In Vitro Diagnostics, Reagents, and Tests. Under this agreement, the VA will be able to efficiently procure point-of-care testing devices, related...
The U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 23 (VISN 23) awarded a Blanket Purchase Agreement (BPA) to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, for the provision of BinaxNOW COVID-19 antigen test kits and related supplies. The BPA, valued at up to $740,000, was issued against Abbott's GSA Schedule 65-VII contract for in vitro diagnostics, reagents, and tests. This award supports VISN 23's ongoing COVID-19 testing and diagnostic needs across its medical facilities, particularly in Florida. The contract does not have a small business set-aside designation. Multiple BPA call orders have been issued to Abbott Rapid DX North America LLC under this vehicle, ranging in value from a few thousand dollars to over $45,000, to enable the VA network to procure the necessary COVID-19 testing products from this key federal supplier. In addition to COVID-19 tests, Abbott has also provided other diagnostic products like HbA1c test cartridges to the VA and Department of Defense under similar contract vehicles.
The original solicitation sought offers for an FDA-approved or Emergency Use Authorization (EUA) Binax NOWA SARS-CoV-2 Antigen Test Kit to support testing needs at 13 VA medical facilities within VISN 23. The BPA requires the test kits to meet specific technical requirements, including lateral flow immunoassay technology, 15-minute or less result availability, and room temperature stability. The contract also stipulates network security and integration requirements if any equipment or instrumentation is required to perform or interpret the test results.